Skip to main content

Fundamentals in Systemic Anti-Cancer Therapies (SACT) Administration and Care (CANC601/CANC6012)

This module runs separately in two semesters. The module code for semester one is CANC601 whilst the module code for semester two is CANC6012. The module allows for the critical evaluation and demonstration competency in the management and care of patients with solid and haematological tumours receiving systemic anti-cancer therapies.

Module delivery

Part-time delivery, with the module delivered in semesters one and two.

Key dates and application information

  • Apply by: 30 November 2024 (January - semester two).
  • Module start date: 6 January 2025
    Module end date: June 2025
  • Apply by: 31 July 2025 (September - semester one)
  • Module start date: September 2025
    Module end date: January 2026.

Module overview

To critically evaluate and demonstrate competency in the management and care of patients with solid and haematological tumours receiving systemic anti-cancer therapies (SACT).

Who is the module for?

The module is designed for practising, registered nurses working in SACT administration roles. The module is a standalone option which can be used to support continuous professional development.

Module details and indicative content

Learners will evaluate the decision making, risk assessment and therapeutic intervention in relation to the management and holistic care of the patient receiving SACT.

You will also examine the professional policy, health and safety regulations and legal aspects relating to the administration of systemic anti-cancer therapy and reflect critically on own professional and clinical skill development.

Additionally, you will analyse the pharmacological properties of anti-cancer drugs and critically evaluate the physiological impact of systemic anti-cancer therapies including chemotherapeutic agents on individuals.

How you are assessed

There are three summative assessments:

  • One practical assessment – completion of the SACT passport (or evidence of prior completion)
  • A 1,500-word critical reflection
  • A 90-minute written examination based on an Online Structured Clinical Exam (OSCE) Clinical Scenario.

A placement may be required to support you with the completion of this. This can be undertaken in your place of work or at The Clatterbridge Cancer Centre. There is a minimum of 75 hours supernumerary to be completed as part of this. Please contact nicola.benson1@nhs.net to discuss this in further detail.